Review
Open access
Aug 2026
Advances in understanding the tumor microenvironment of neuroendocrine prostate cancer
Longitudinal biopsies, spatial multi-omics, humanized models and biomarker-defined trials are needed to distinguish causal vulnerabilities from correlates of treatment-emergent lineage transition.
Nan Yao, Qi-Xing Yang, Peng-Kang Chang et al.
· Frontiers in Oncology · 0 citations